Skip to main content
. Author manuscript; available in PMC: 2010 Jul 10.
Published in final edited form as: J Neurochem. 2007 Aug 30;103(4):1491–1505. doi: 10.1111/j.1471-4159.2007.04858.x

Fig. 5.

Fig. 5

(a) Measurement of axon length from RGCs growing on OPN, laminin-111, and a mixture of osteopontin (OPN)/laminin-111 (0.5×) after 24 h treated with the CD44 (CD44as) and control (CD44mb) deoxyribozymes (8 µmol/L) or left untreated. (b) Demonstrates the overall survival rate of RGCs under any of our experimental conditions (substrate or treatment). No statistical difference was observed between these various conditions.